Stitchless dialysis artificial blood vessel
By designing seamless conical artificial blood vessels, using nickel-titanium alloy stents and polymer layers to enhance radial support, the problems of high suture difficulty and postoperative infection in the existing technology are solved, realizing immediate puncture and reducing complications effect.
Patent Information
- Application Number
- CN202411448919.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-17
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing artificial blood vessels need to be sutured when used, which makes the operation difficult and prone to complications such as infection, bleeding, thrombosis, hematoma, etc., and after the operation, the arteriovenous fistula matures before puncture is punctured, which extends the treatment time.
A seamless dialysis artificial blood vessel was designed, with a coating segment, a venous end segment and an arterial end segment with a cone structure. The middle layer is a wavy nickel-titanium alloy stent, and the outer layer is a polymer layer and microporous electrospinning. The silk film, the venous end and the arterial end are composed of multi-layer wavy nickel-titanium alloy wires. The coated segment and the bare segment are connected by a developing ring, omitting the suture step, enhancing the radial support force, and supporting immediate puncture.
The suture-related complications are avoided, the risk of postoperative infection is reduced, immediate puncture is allowed, the radial support of the blood vessels is improved, and the incidence of hematoma and pseudoaneurysm is reduced.
Smart Images

Figure CN118948490A_ABST
Abstract
Description
Technical Field
[0001] The invention patent relates to the field of medical devices, and in particular to a seamless dialysis artificial blood vessel. Background Art
[0002] Hemodialysis (HD): It is one of the renal replacement therapies for patients with acute and chronic renal failure. It drains blood from the body to the outside of the body, removes metabolic wastes through a dialyzer, and then returns the purified blood to the body. The whole process is called hemodialysis.
[0003] Hemodialysis requires a blood flow of more than 300 ml / min, and a vascular access needs to be established. Currently, there are three methods for establishing permanent vascular access: autologous arteriovenous fistula (AVF), graft fistula (artificial blood vessel AVG), and central venous catheter. Arteriovenous fistula is constructed using artificial vascular grafts, which we call artificial vascular graft fistula (AVG). That is to say, one end of the artificial blood vessel is anastomosed to the autologous artery, and the other end is anastomosed to the autologous vein, thus forming an arteriovenous access. When hemodialysis is needed, the artificial blood vessel can be directly punctured.
[0004] When using existing artificial blood vessels, open surgery is required to separate the arteries and veins from the tissues, make holes where the anastomosis is to be established, and then sew the artificial blood vessels to the arteriovenous anastomosis. The entire surgical process is difficult, especially when suturing, the anastomosis and the artificial blood vessel port need to be sutured neatly, tightly, and evenly. Bleeding from the suture hole is the reason for increased blood loss and increased operation time. If the suturing is not done well, it is easy to cause complications such as infection, bleeding, thrombosis, hematoma, hyperplastic stenosis, etc.
[0005] At the same time, in order to reduce infection after surgery, it is necessary to wait at least 1-3 days before puncture can be performed. For some patients who urgently need dialysis as soon as possible, the treatment time is extended and the timely treatment of patients is affected.
[0006] At the same time, because current artificial blood vessels are usually made of expanded polytetrafluoroethylene plus silicone, such as ACUSEAL from Gore, whose three-layer ePTFE artificial blood vessels are used for early clinical dialysis vascular access, this artificial blood vessel has low radial support force and is prone to collapse during puncture and dialysis, or excessive puncture, puncturing the entire artificial blood vessel, and causing complications such as postoperative hematoma and pseudoaneurysm.
[0007] Therefore, an artificial blood vessel that can solve the above problems is of great significance. To this end, we propose a seamless dialysis artificial blood vessel, which has the following beneficial effects: 1. The step of suturing the artificial blood vessel with the blood vessel is omitted; 2. The possibility of complications such as infection and hematoma after suturing the artificial blood vessel with the blood vessel is avoided; 3. There is no need to wait for the arteriovenous fistula to mature, and puncture can be performed immediately after surgery; 4. Compared with traditional artificial blood vessels, the artificial blood vessel of the present invention has higher radial support force. Summary of the invention
[0008] The purpose of the present invention is to overcome the above disadvantages and provide a sutureless dialysis artificial blood vessel.
[0009] The technical solution adopted by the present invention is as follows: An artificial blood vessel, the artificial blood vessel comprising a coated section, a bare section at a venous end and a bare section at an arterial end, the coated section, the bare section at the venous end and the bare section at the arterial end being of a conical structure, the end of the coated section with a larger diameter being connected to the bare section at the venous end, the end with a smaller diameter being connected to the bare section at the arterial end, and developing rings being respectively arranged between the coated section and the bare sections at the arterial end and the venous end; the coated section being of a multi-layer structure, the inner layer being an ePTFE tubular membrane, the middle layer being a wavy nickel-titanium alloy stent, the outer side of the nickel-titanium alloy stent being provided with a polymer layer, and the outer side of the polymer layer being provided with an electrospun membrane with micropores; the bare sections at the venous end and the arterial end being formed by mutually intertwining multiple layers of wavy nickel-titanium alloy wires, the end with a smaller diameter of the bare section at the venous end being connected to the end with a larger diameter of the coated section, the end with a smaller diameter of the bare section at the arterial end being connected to the section with a smaller diameter of the coated section, and the artificial blood vessel as a whole being a structure of two cones connected end to end; A delivery system, the delivery system comprising a TIP head, a delivery section, a tube body, a seat and an outer sleeve; the TIP head is located at the tip of the delivery system and is a conical structure; the artificial blood vessel is bound by a binding wire to the delivery section; the outer sleeve is sleeved on the artificial blood vessel bound by the binding wire; the tube body is connected to the delivery section, and the tube body is a multi-cavity structure, including a guide wire cavity, a binding wire cavity, a first positioning cavity and a second positioning cavity; the seat is connected to the tube body, and a guide wire port, a binding wire port, a first positioning port and a second positioning port are provided on the seat, and a first rotating handle and a second rotating handle are provided on the first positioning port and the second positioning port; a first traction wire and a second traction wire are provided in the first positioning cavity and the second positioning cavity, one end of the first and second traction wires are connected to the two ends of the coating section, and the other end is connected to the first and second rotating handles.
[0010] Preferably, the outer side of the coating section is coated with hyaluronic acid, and the inner side is coated with heparin.
[0011] Preferably, the coated section of the artificial blood vessel is bounded to the delivery section by the binding wire.
[0012] Preferably, the bare section of the artificial blood vessel is pressed and gripped by the outer sleeve against the coated section.
[0013] Preferably, the diameter of the bare segment at the venous end is 3mm-9mm, and the diameter of the bare segment at the arterial end is 1.5mm-6mm.
[0014] Preferably, the bare sections of the arterial end and the venous end are provided with holes.
[0015] Preferably, the diameter of the hole in the bare segment at the arterial end is 0.5 mm-5 mm, and the diameter of the hole in the bare segment at the venous end is 1 mm-7 mm. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 Schematic diagram of a sutureless dialysis vascular graft; Figure 2 Cross-section of the film coating section; Figure 3 Schematic diagram of the conveying system; Figure 4 Cross-section of the tube body; Figure 5 Schematic diagram of puncture catheter; Figure 6 The process of puncturing blood vessels; Figure 7 Schematic diagram of sutureless dialysis graft placement (before adjustment); Figure 8 Schematic diagram of sutureless dialysis graft placement (after adjustment); Fig. 9 Another structural schematic diagram of the coating section. DETAILED DESCRIPTION
[0017] The following embodiments of the present invention are described in further detail in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
[0018] A seamless dialysis artificial blood vessel, characterized in that it comprises: an artificial blood vessel 100, wherein the artificial blood vessel 100 comprises an intermediate coated section 110, a bare section at the venous end 120, and a bare section at the arterial end 130. The intermediate coated section 110, the bare section at the venous end 120, and the bare section at the arterial end 130 are in a tapered variable diameter structure, and the larger diameter end of the coated section 110 is connected to the bare section at the venous end 120, and the smaller diameter end is connected to the bare section at the arterial end 130, so as to match the size of the blood vessel changes and facilitate the fixed positioning of the bare section stent in the blood vessel. The diameter range of the bare section at the venous end 120 is 3mm-9mm, and the diameter range of the bare section at the arterial end 130 is 1.5mm-6mm. The middle coating section 110 includes a developing ring 111, 112 at both ends, and the developing ring is located between the middle coating section and the bare arteriovenous section for intraoperative visualization and positioning; the middle coating section 110 includes a multi-layer structure, the innermost layer is an ePTFE tubular film 116, and the outer layer of the tubular film is a wavy nickel-titanium alloy stent 115, whose wavy structure makes the artificial blood vessel have good flexibility, and the nickel-titanium alloy stent 115 makes the artificial blood vessel have good radial support force, which is convenient for puncture and prevents To prevent the artificial blood vessel from collapsing during puncture, a polymer layer 114 is provided on the outer surface of the nickel-titanium alloy stent 115 for fixing the nickel-titanium stent. The polymer layer is a dense structure without holes or micropores. The outer layer of the polymer layer 114 is an electrospun membrane 113 with micropores. The micropores on the surface of the electrospun membrane 113 allow cell tissue to grow into the artificial blood vessel, thereby fixing the artificial blood vessel in the human body and preventing displacement. The micropore structure is disordered and non-oriented. After puncture by the dialysis needle, the puncture hole can quickly rebound and close to prevent Stop bleeding. A layer of hyaluronic acid is coated on the outer surface of the electrospun membrane 113 to help the tissue grow quickly and grow into the microporous structure of the electrospun membrane 113, so that the artificial blood vessel is fixed to the tissue. At the same time, a composite layer of polymer membrane and tissue is formed to increase its toughness and prevent bleeding after dialysis puncture. The inside of the coated section 110 is coated with a heparin coating to inhibit the formation of thrombus after the artificial blood vessel is implanted. The smaller diameter end of the bare segment 120 of the venous end is connected to the larger diameter end of the middle coated section 110. The bare segment 120 of the venous end has a variable diameter structure. The structure of the bare segment 120 of the venous end is that the ring segments are connected to each other. It is composed of multiple layers of wavy nickel-titanium alloy wires that are intertwined. The crest of one layer is connected to the trough of the adjacent layer, or the trough of one layer is connected to the crest of the adjacent layer. A hole 121 is formed at the connection. The bare segment has a certain degree of free expansion and contraction ability. The diameter of the hole 121 is relatively large, and the pore size range is 1mm-7mm, which is convenient for blood flow. It has good radial support force and is used to support blood vessels. The arterial bare segment 130 is a variable diameter structure, the smaller diameter end of the arterial bare segment 130 is connected to the smaller diameter end of the middle coated segment 110, and its bare segment structure is the same as the venous bare segment 120. The diameter of the hole 131 of the arterial bare segment is smaller than that of the venous bare segment 120, and the hole diameter ranges from 0.5mm to 5mm. The artificial blood vessel as a whole is a structure of two cones connected end to end.
[0019] The delivery system 200 includes a tip head 210, a delivery section 280, a tube body 230, a seat 240, and an outer sleeve 250. The tip head 210 is a conical flexible structure to avoid damaging the blood vessel; the delivery section 280 is wrapped with a bound artificial blood vessel 100, the artificial blood vessel coating section 110 is bound and bound to the delivery section 280 by a binding wire, and the venous end bare section 120 and the arterial end bare section 130 are pressed and held on the delivery section 280 by the outer sleeve 250. When the artificial blood vessel 100 is pushed out of the outer sleeve 250, the venous end bare section 120 and the arterial end bare section 130 automatically expand, while the coating section 110 is still bound by the binding wire, and the binding wire needs to be pulled to release it before the coating section 110 can expand; the tube body 230 is a polymer multi-lumen tube, connected to the delivery section, including a guide wire cavity 231, a binding wire cavity 232, a first positioning cavity 233, and a second positioning cavity 234; The seat 240 is connected to the tube body 230. The seat 240 is provided with a guide wire port 242, a wire binding port 241, a first positioning port and a second positioning port. The first positioning port and the second positioning port are provided with a first rotating handle 243 and a second rotating handle 244. The first positioning cavity 233 and the second positioning cavity 234 are provided with a first traction wire 122 and a second traction wire 132. One end of the first traction wire 122 is connected between the coated segment 110 and the bare segment 120 at the venous end, and the other end is connected to the first rotating handle. One end of the second traction wire 132 is connected between the coated segment 110 and the bare segment 130 at the arterial end, and the other end is connected to the second rotating handle. The first and second traction wires are used to adjust the angle of the artificial blood vessel coated segment 110 so that the cross section of the artificial blood vessel coated segment is parallel to the cross section of the blood vessel wall, thereby reducing the influence of the artificial blood vessel coated segment on the blood flow in the blood vessel.
[0020] When the artificial blood vessel 100 is used, the puncture catheter 300 is first used to enter from the vein end and puncture the distal end of the vein to connect the artery and vein. The puncture catheter 300 includes a catheter 310 and a puncture needle 320, wherein the catheter 310 is mainly used to transport the puncture needle to the puncture site, and the puncture needle 320 is a nickel-titanium arc structure, which is convenient for puncturing and connecting the artery and vein. After the puncture is completed, a guide wire 330 is inserted to guide the subsequent delivery system, such as Figure 6 shown.
[0021] The artificial blood vessel 100 is initially released. Figure 7 As shown, the cross-sections of the two ends of the coated section 110 are not parallel to the blood vessel wall, and the handle is rotated to adjust the stent. For example, at the venous end, when releasing, first ensure that the distal end 142 of the coated section is flush with or in a suitable position with the distal end of the inner wall of the blood vessel, and then stretch the proximal end 141 of the coated section by the first rotating handle 243 to adjust the angle of the stent so that it is flush with or in a suitable position with the proximal end of the inner wall of the blood vessel. Figure 8As shown, at this time, the bare segment 120 at the venous end is compressed due to the stretching of the coated segment. When the arterial end is released, first ensure that the proximal end 144 of the coated segment cross section is flush with or in a suitable position with the proximal end of the inner wall of the blood vessel, and then pull back the distal end 143 of the coated segment cross section through the second rotating handle 244 to adjust the angle of the stent so that it is flush with or in a suitable position with the proximal end of the inner wall of the blood vessel. At this time, the coated segment can completely close the blood flow holes of the artery and vein, and at the same time, the blood flow at the distal end of the artery and vein is less affected.
[0022] In another embodiment, in the coating section 110 of the artificial blood vessel 100, the inner and outer membrane materials are both PCL degradable materials, and a nickel-titanium alloy stent 115 is embedded in the middle to support the artificial blood vessel 100. Through spraying, the PCL material forms a porous artificial blood vessel wall 117, and evenly wraps the nickel-titanium stent inside. After being implanted in the human body for a period of time, the tissue continues to grow into the holes of the membrane, and the original coating continues to degrade. After a period of time, a composite membrane of polymer material and tissue is formed. After a period of degradation, the degradable material is completely degraded. At this time, the artificial blood vessel only contains the nickel-titanium stent 115 and the newly generated artificial blood vessel wall. At this time, the artificial blood vessel has a higher supporting force to facilitate puncture and dialysis, and at the same time, because the artificial blood vessel wall is self-generated, the incidence of thrombosis and hyperplasia is reduced.
[0023] The described embodiments are to be considered in all respects as illustrative only and not restrictive. Therefore, the scope of the present disclosure is indicated by the appended claims rather than by the preceding description. All changes within the equivalent meaning and scope of the claims are included within their scope. The present invention is not limited to the above-described embodiments, which does not mean that the present invention must rely on the above-described embodiments to be implemented. Those skilled in the art should understand that any improvements to the present invention, equivalent replacement of the raw materials selected by the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the scope of protection and disclosure of the present invention.
Claims
1. A seamless dialysis artificial blood vessel, characterized in that: include: An artificial blood vessel, the artificial blood vessel comprising a coated section, a bare section at a venous end and a bare section at an arterial end, the coated section, the bare section at the venous end and the bare section at the arterial end being of a conical structure, the end of the coated section with a larger diameter being connected to the bare section at the venous end, the end with a smaller diameter being connected to the bare section at the arterial end, and developing rings being respectively arranged between the coated section and the bare sections at the arterial end and the venous end; the coated section being of a multi-layer structure, the inner layer being an ePTFE tubular membrane, the middle layer being a wavy nickel-titanium alloy stent, the outer side of the nickel-titanium alloy stent being provided with a polymer layer, and the outer side of the polymer layer being provided with an electrospun membrane with micropores; the bare sections at the venous end and the arterial end being formed by mutually intertwining multiple layers of wavy nickel-titanium alloy wires, the end with a smaller diameter of the bare section at the venous end being connected to the end with a larger diameter of the coated section, the end with a smaller diameter of the bare section at the arterial end being connected to the section with a smaller diameter of the coated section, and the artificial blood vessel as a whole being a structure of two cones connected end to end; A delivery system, the delivery system comprising a TIP head, a delivery section, a tube body, a seat and an outer sleeve; the TIP head is located at the tip of the delivery system and is a conical structure; the artificial blood vessel is bound by a binding wire to the delivery section; the outer sleeve is sleeved on the artificial blood vessel bound by the binding wire; the tube body is connected to the delivery section, and the tube body is a multi-cavity structure, including a guide wire cavity, a binding wire cavity, a first positioning cavity and a second positioning cavity; the seat is connected to the tube body, and a guide wire port, a binding wire port, a first positioning port and a second positioning port are provided on the seat, and a first rotating handle and a second rotating handle are provided on the first positioning port and the second positioning port; a first traction wire and a second traction wire are provided in the first positioning cavity and the second positioning cavity, one end of the first and second traction wires are connected to the two ends of the coating section, and the other end is connected to the first and second rotating handles.
2. A sutureless dialysis artificial blood vessel according to claim 1, characterized in that: The outer side of the coating section is coated with hyaluronic acid, and the inner side is coated with heparin.
3. The sutureless dialysis artificial blood vessel according to claim 1, characterized in that: The coated section of the artificial blood vessel is bounded by the binding wire to the delivery section.
4. The sutureless dialysis artificial blood vessel according to claim 1, characterized in that: The bare section of the artificial blood vessel is pressed and gripped by the outer sleeve on the coated section.
5. The sutureless dialysis artificial blood vessel according to claim 1, characterized in that: The diameter of the bare segment at the venous end is 3mm-9mm, and the diameter of the bare segment at the arterial end is 1.5mm-6mm.
6. The sutureless dialysis artificial blood vessel according to claim 1, characterized in that: The bare sections of the arterial end and the venous end are provided with holes.
7. The sutureless dialysis artificial blood vessel according to claim 6, characterized in that: The diameter of the hole of the bare segment at the arterial end is 0.5mm-5mm, and the diameter of the hole of the bare segment at the venous end is 1mm-7mm.
Citation Information
Patent Citations
Implantable and removable customizable body conduit
CN103517685A
Steering wire attach for angulation
CN110650708A
Blood vessel suture-free device, suture-free artificial blood vessel and conveying system
CN116350390A
Puncture covered stent
CN117297835A
Implantable and removable customizable body conduit
US20110295181A1
